Aclaris Therapeutics, Inc. - COM (ACRS)

Historical Portfolio Holders from Q4 2015 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
53.7 M
Holdings value Q1 2024
$66.5 M
Value change Q1 2024
-$3.19 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
90
Number of buys Q1 2024
41
Number of sells Q1 2024
-63
Average buys Q1 2024 %
+0.001%
Average sells Q1 2024 %
0%
CUSIP
00461U105
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 53.7 M $66.5 M -$3.19 M $1.24 90
2023 Q4 57.3 M $60.1 M -$206 M $1.05 100
2023 Q3 70 M $479 M -$28.1 M $6.85 140
2023 Q2 71 M $736 M +$5.84 M $10.37 131
2023 Q1 71.6 M $579 M +$19.7 M $8.09 149
2022 Q4 65.8 M $1.04 B -$2.52 M $15.75 125
2022 Q3 63.5 M $1 B +$4.19 M $15.74 120
2022 Q2 63.2 M $883 M +$55.6 M $13.96 109
2022 Q1 59.1 M $1.02 B +$65.5 M $17.24 105
2021 Q4 55.9 M $813 M -$38.6 M $14.54 128
2021 Q3 56.7 M $1.02 B +$15.1 M $18.00 124
2021 Q2 56 M $983 M +$174 M $17.56 128
2021 Q1 45.4 M $1.14 B +$405 M $25.20 94
2020 Q4 30.4 M $197 M +$26.7 M $6.47 75
2020 Q3 24.2 M $62.2 M -$3.89 M $2.57 49
2020 Q2 28.4 M $46.1 M -$5.4 M $1.62 52
2020 Q1 28.8 M $29.9 M +$5.25 M $1.04 55
2019 Q4 28.1 M $53.1 M +$4 M $1.89 67
2019 Q3 25.9 M $28 M -$18.8 M $1.08 66
2019 Q2 32.5 M $71.2 M -$14.4 M $2.19 76
2019 Q1 37.4 M $224 M -$10.8 M $5.99 86
2018 Q4 38.8 M $287 M +$36.7 M $7.39 88
2018 Q3 29.1 M $422 M -$34.4 M $14.52 76
2018 Q2 31 M $619 M +$11.6 M $19.97 89
2018 Q1 30.2 M $528 M +$32.3 M $17.52 95
2017 Q4 28.5 M $702 M -$5.46 M $24.66 98
2017 Q3 28.5 M $735 M +$71.5 M $25.81 102
2017 Q2 25.6 M $694 M +$24 M $27.12 101
2017 Q1 23.6 M $703 M +$73.9 M $29.82 109
2016 Q4 21.2 M $577 M +$94.9 M $27.14 99
2016 Q3 15.5 M $396 M +$5.2 M $25.61 59
2016 Q2 15.4 M $283 M +$12.2 M $18.47 47
2016 Q1 14.6 M $277 M +$2.03 M $18.95 33
2015 Q4 10.3 M $277 M +$208 M $26.94 31